September 17, 2019

Zomedica names Dr. Stephanie Morley President

September 3, 2019

Zomedica to Present at RHK Capital 2019 Disruptive Growth Conference, Fall Investor Summit, and Sidoti & Company Fall 2019 Investor Conference

August 19, 2019

Animal Health Veteran Johnny D. Powers Joins Zomedica Board of Directors

August 8, 2019

Zomedica Announces Second Quarter 2019 Financial Results

August 7, 2019

Zomedica Announces TRUFORMA™ Assay Updates and R&D Expansion

July 25, 2019

Zomedica’s Dr. Bonnie Bragdon to Speak at AVMA Convention 2019 on Sunday, August 4

July 17, 2019

Zomedica Announces Initiation of a Digital Data Platform Enhancing its Diagnostic Pipeline

June 13, 2019

Zomedica Announces Completion of Initial Development of a Lymphoma Assay for its Canine Cancer Liquid Biopsy Platform

June 12, 2019

Zomedica to Present at Raymond James Life Sciences and MedTech Conference

June 10, 2019

Zomedica Announces $7 Million Second Tranche Closing of Preferred Shares

May 21, 2019

Zomedica Announces Achievement of Product Development Milestones on its TRUFORMA™ Point-of-Care Diagnostic Platform

May 10, 2019

Zomedica Announces First Quarter 2019 Financial Results

May 10, 2019

Zomedica Announces Private Placement of Preferred Shares

March 26, 2019

Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares

March 25, 2019

Zomedica Pharmaceuticals Corp. Announces Proposed Public Offering of Common Shares

March 5, 2019

Zomedica Initiates ZM-006 Pilot Efficacy Study and Provides Corporate Updates

February 26, 2019

Zomedica Pharmaceuticals Corp. Announces Year End 2018 Financial Results

January 15, 2019

Zomedica Appoints Dr. Bonnie Bragdon as Vice President of Veterinary Affairs

January 14, 2019

Zomedica Announces $4.28 Million Private Placement Closing and Corporate Update